About Prenetics
Prenetics is a company based in Hong Kong (China) founded in 2009 by Michael M Yang and Danny Yeung.. Prenetics has raised $67.65 million across 6 funding rounds from investors including David Beckham, Apis Partners and Alibaba Entrepreneurs Fund. The company has 285 employees as of December 31, 2024. Prenetics has completed 6 acquisitions, including ACT Genomics, DNAFit and Europa Sports Products. Prenetics offers products and services including CircleDNA, Insighta, ACT Genomics, and IM8. Prenetics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Hong Kong, China
- Employees 285 as on 31 Dec, 2024
- Founders Michael M Yang, Danny Yeung
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Prenetics Global Limited
-
Annual Revenue
$30.62 M40.83as on Dec 31, 2024
-
Net Profit
$-46.3 M26.18as on Dec 31, 2024
-
EBITDA
$-44.96 M-0.54as on Dec 31, 2024
-
Total Equity Funding
$67.65 M (USD)
in 6 rounds
-
Latest Funding Round
$48 M (USD), Post-IPO
Oct 27, 2025
-
Investors
Apis Partners
& 19 more
-
Employee Count
285
as on Dec 31, 2024
-
Investments & Acquisitions
ACT Genomics
& 5 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Prenetics
Prenetics is a publicly listed company on the NASDAQ with ticker symbol PRE in USA, operating in the Finance sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Prenetics
Prenetics offers a comprehensive portfolio of products and services, including CircleDNA, Insighta, ACT Genomics, and IM8. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers personalized DNA tests for health management and prevention.
Provides multi-cancer screening technologies for early diagnosis.
Delivers genomic profiling for solid tumor treatments.
Focuses on health supplements and wellness products for consumers.
Unlock access to complete
Unlock access to complete
Funding Insights of Prenetics
Prenetics has successfully raised a total of $67.65M across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $48 million completed in October 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $48.0M
-
First Round
First Round
(03 Dec 2014)
- Investors Count 20
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2025 | Amount | Post-IPO - Prenetics | Valuation |
investors |
|
| Jul, 2024 | Amount | Post-IPO - Prenetics | Valuation |
investors |
|
| Sep, 2020 | Amount | Series B - Prenetics | Valuation | Apis Partners |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Prenetics
Prenetics has secured backing from 20 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include David Beckham, Apis Partners and Alibaba Entrepreneurs Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and venture capital asset management firm
|
Founded Year | Domain | Location | |
|
Capital and guidance are provided to startups for growth.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided by Beyond Ventures for startups.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Prenetics
Prenetics has strategically engaged in corporate development activities, having acquired 6 companies. Notable acquisitions include ACT Genomics, DNAFit and Europa Sports Products. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
End-to-end fulfillment solutions are provided to ecommerce brands by Hubmatrix.
|
2020 | ||||
|
Diagnostics solutions for COVID-19 infections are provided using RT-LAMP technology.
|
2020 | ||||
|
Genomics services for cancer clinical and research needs are delivered.
|
2014 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Prenetics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Prenetics Comparisons
Competitors of Prenetics
Prenetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Prenetics
Frequently Asked Questions about Prenetics
When was Prenetics founded?
Prenetics was founded in 2009 and raised its 1st funding round 5 years after it was founded.
Where is Prenetics located?
Prenetics is headquartered in Hong Kong, China.
Who is the current CEO of Prenetics?
Danny Yeung is the current CEO of Prenetics. They have also founded this company.
Is Prenetics a funded company?
Prenetics is a funded company, having raised a total of $67.65M across 6 funding rounds to date. The company's 1st funding round was a Series B of $15M, raised on Dec 03, 2014.
How many employees does Prenetics have?
As of Dec 31, 2024, the latest employee count at Prenetics is 285.
What is the annual revenue of Prenetics?
Annual revenue of Prenetics is $30.62M as on Dec 31, 2024.
What does Prenetics do?
Prenetics was founded in 2009 in Hong Kong, China, within the health technology sector. An online platform is operated for genetic and diagnostic testing to identify health risks. Covid-19 PCR tests and rapid test kits have been developed, with samples analyzed via whole-genome sequencing. A DNA screening test for colon cancer detection has also been created, supporting diagnostic services in the region.
Who are the top competitors of Prenetics?
Prenetics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does Prenetics offer?
Prenetics offers CircleDNA, Insighta, ACT Genomics, and IM8.
Is Prenetics publicly traded?
Yes, Prenetics is publicly traded on NASDAQ under the ticker symbol PRE.
How many acquisitions has Prenetics made?
Prenetics has made 6 acquisitions, including ACT Genomics, DNAFit, and Europa Sports Products.
Who are Prenetics's investors?
Prenetics has 20 investors. Key investors include David Beckham, Apis Partners, Alibaba Entrepreneurs Fund, Beyond Ventures, and Ping An Ventures.
What is Prenetics's ticker symbol?
The ticker symbol of Prenetics is PRE on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.